Healthcare Svcs Group Inc SEC Filings

Healthcare Services Group (HCSG) executive EVP & Chief Operating Officer filed a Form 4 reporting an open-market sale of 28,612 shares of common stock on 10/28/2025 at a weighted average price of $19.13.

Following the transaction, the reporting person beneficially owns 18,859 shares, held directly. The filing notes the sale was executed in multiple trades and that detailed trade breakdowns are available upon request.

Healthcare Services Group (HCSG) reported stronger Q3 2025 results. Revenue rose to $464,338 thousand and net income increased to $42,953 thousand, translating to diluted EPS of $0.59. Operating performance reflected lower interest expense and higher investment income.

Results were shaped by special items. The company received Employee Retention Credit refunds of $31.8 million in the quarter ($51.8 million year‑to‑date), recognized $34.2 million as a reduction to costs of services and $5.3 million of related interest income, and recorded a $12.3 million deferred ERC liability tied to a 2021 period. Credit risk remained elevated: following Genesis Healthcare’s Chapter 11 filing, HCSG applied a 100% allowance to Genesis receivables and recorded bad debt expense of $2.7 million in Q3 and $63.9 million year‑to‑date. Cash, cash equivalents and restricted cash equivalents ended at $124,420 thousand, supported by net cash provided by operating activities of $127,581 thousand for the nine months. The company also repurchased $27,271 thousand of treasury stock in Q3.

Healthcare Services Group, Inc. (HCSG) furnished a press release announcing its earnings for the three months ended September 30, 2025. The press release is provided as Exhibit 99.1 and incorporated by reference.

The company states that the information, including Exhibit 99.1, is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. An Inline XBRL cover page (Exhibit 104) is included.

Kurt Simmons Jr., a director of Healthcare Services Group, Inc. (HCSG), reported acquiring 892 shares of common stock on 09/30/2025 at an effective price of $16.83 per share by electing to receive shares in lieu of cash board fees under the company's 2020 Omnibus Incentive Plan. The election was made in November 2024 and applies to fees earned in 2025 in compliance with the issuer's blackout guidelines. Following the reported transaction, Simmons beneficially owns 26,596 shares in total, consisting of 23,790 vested DSUs and 2,806 unvested DSUs. The DSUs are fully vested and will be settled in shares 90 days following separation from the board, with an option for further deferral under Code Section 409A. The Form 4 was signed by power of attorney on 10/02/2025.

Thomas Gerard Whalen, a director of Healthcare Services Group, Inc. (HCSG), reported an acquisition on 09/30/2025 of 149 shares of common stock at an effective price of $16.83 per share. The shares reflect the election to receive fully vested Deferred Stock Units (DSUs) instead of cash director fees for 2025; the filing states the election was made in May 2025. The report breaks the total into 2,806 unvested DSUs and 214 vested DSUs, and notes DSUs will be settled in shares 90 days after separation from board service, with an option for further deferral under Code Section 409A.

Mackenzie Financial Corporation reports beneficial ownership of 4,128,499 common shares of Healthcare Services Group Inc., representing 5.66% of the class. The filing states Mackenzie holds sole voting and dispositive power over these shares and that the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. The statement is filed under Schedule 13G reporting rules and identifies Mackenzie as an investment adviser organized in Ontario, Canada, with the shares listed under CUSIP 421906108. The filing includes a certification of accuracy signed by Mackenzie’s Vice‑President & Chief Compliance Officer.